Nigeria: NCDC investigating blood clotting in early recipients of AstraZeneca vaccine
- Country:
- Nigeria
The Nigeria Center for Disease Control (NCDC) is undergoing investigation on blood clotting in some of the people who received first jabs of the AstraZeneca vaccine, according to a report by Daily Post.
Chikwe Ihekweazu, the National Coordinator of NCDC, said at the Presidential Task Force (PTF) while briefing press on COVID-19.
Earlier on Tuesday, the European Medicines Agency made an announcement stating a causal link between AstraZeneca’s COVID-19 and rare blood clots. However, Marco Cavaleri, head of the valuation team, Health Threats and Vaccine Strategy, told a Roman newspaper that a definitive statement on the link would be released this week.
“Actions will be taken after data and circumstances are fully evaluated,” Ihekweazu added.
- READ MORE ON:
- Nigeria
- NCDC
- COVID-19
- AstraZeneca
- European Medicines Agency
- PTF
- NPHCDA
- NAFDAC
ALSO READ
BRIEF-Astrazeneca Says All Resolutions Were Supported At Today's AGM
My taxable income plummeted to Rs 680 in 2021-22 due to Covid-19 losses: BJP's Chandrasekhar
BRIEF-Astrazeneca To Increase 2024 Dividend By 7%
AstraZeneca shareholders approve 2024 pay policy at AGM
AstraZeneca shareholders approve 2024 pay policy in boost to CEO Soriot